Furthermore, by upregulating PPAR expression and suppressing inflammatory cytokine levels, fibroblast growth factor 21 (FGF-21) reduces pulmonary hypertension and suppressing inflammatory cytokine levels. Here, FGF21 is linked to pulmonary arterial hypertension.